Drug
Icodextrin Peritoneal Dialysis Solution
Icodextrin Peritoneal Dialysis Solution is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
2(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
unknown1
Recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (100.0%)
Trials by Status
unknown133%
recruiting133%
completed133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_4
Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis
NCT05721404
completed
Observational Study of the Use of Extraneal in Peritoneal Dialysis in Patients
NCT06492031
unknownphase_4
The Difference Between Daily and Alternative Day Use of Icodextrin
NCT05943470
Clinical Trials (3)
Showing 3 of 3 trials
NCT05721404Phase 4
Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis
NCT06492031
Observational Study of the Use of Extraneal in Peritoneal Dialysis in Patients
NCT05943470Phase 4
The Difference Between Daily and Alternative Day Use of Icodextrin
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3